IGC Pharma, Inc. — Director's Dealing 2021

Sep 15, 2021

SEC Form 3/A — Form 3/A

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-05-13

Reporting Person: LYNCH John Edward (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	96901	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
OPTIONS	$1.39	2031-03-31	COMMON STOCK (150000)		Direct

Footnotes

F1: Represents the balance of shares purchased when options for previous agreements for advisory services with Mr. Lynch where exercised.

F2: Represents options to purchase 150,000 shares of IGC's common stock as per the Option Agreement with Director Lynch. Director Lynch, which were previously reported incorrectly
as 150,000 Shares of Common Stock awarded to him.